Modular Medical, Inc.
Modular Medical, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 4 | 7 | 3 | 5 | 8 | 13 | 7 | 4 | 5 | 9 | 2 | 6 | |||||
Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | 5 | 8 | 3 | 6 | 8 | 14 | 7 | 4 | 5 | 10 | 2 | 6 | |||||
Property Plant And Equipment Net | 7 | 7 | 6 | 6 | 5 | 4 | 4 | 4 | 4 | 3 | 3 | 2 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Other Assets Noncurrent | - | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Assets | 12 | 15 | 10 | 13 | 14 | 19 | 12 | 9 | 10 | 14 | 6 | 10 | |||||
Assets Noncurrent | - | - | - | - | - | 5 | - | - | - | 4 | 4 | 4 | |||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 1 | 1 | 1 | 3 | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | |||||
Accrued Liabilities Current | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 1 | 2 | 2 | 4 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Long Term Liabilities | |||||||||||||||||
Operating Lease Liability Noncurrent | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities | 1 | 2 | 4 | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 130 | 126 | 112 | 108 | 103 | 102 | 90 | 82 | 78 | 77 | 65 | 64 | |||||
Retained Earnings Accumulated Deficit | -119 | -113 | -107 | -99 | -91 | -85 | -80 | -75 | -70 | -66 | -62 | -56 | |||||
Stockholders Equity | 11 | 13 | 6 | 9 | 12 | 17 | 10 | 7 | 8 | 12 | 4 | 8 | |||||
Liabilities And Stockholders Equity | 12 | 15 | 10 | 13 | 14 | 19 | 12 | 9 | 10 | 14 | 6 | 10 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 250 | 250 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 50 | 50 | |||||
Common Stock Shares Issued | 6 | 5 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Shares Outstanding | 6 | 5 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2027 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2026 | -2.85% | -7.73% | -32.84% | -14.45% | -27.77% | -15.38% | -51.09% | -64.26% | -72.49% | -48.57% | - | - |
| 2025 | 37.58% | 39.39% | 33.33% | -21.03% | -32.24% | -40.19% | -23.65% | -23.48% | -9.57% | -6.58% | -1.45% | -5.79% |
| 2024 | - | - | - | 48.72% | 52.99% | 47.01% | 46.46% | 25.20% | 26.77% | 7.43% | 6.08% | 53.38% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 3.25 | 4.03 | 1.59 | 1.47 | 4.04 | 10.69 | 5.30 | 3.36 | 4.03 | 6.66 | 1.63 | 5.81 | |||||
| Quick Ratio | 2.63 | 3.71 | 1.35 | 1.31 | 3.67 | 10.35 | 5.05 | 3.13 | 3.76 | 6.35 | 1.42 | 5.69 | |||||
| Working Capital | 3.36M | 5.67M | 1.29M | 1.90M | 6.24M | 12.25M | 5.95M | 2.93M | 4.07M | 8.24M | 903.00K | 5.35M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.14 | 0.14 | 0.74 | 0.48 | 0.20 | 0.10 | 0.18 | 0.27 | 0.26 | 0.20 | 0.61 | 0.27 | |||||
| Interest Coverage TTM | - | - | - | - | - | - | - | - | - | - | - | -25,333.71 | |||||
| Debt Ratio | 0.12 | 0.13 | 0.43 | 0.32 | 0.16 | 0.09 | 0.16 | 0.21 | 0.20 | 0.16 | 0.38 | 0.21 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -5.14 | -12.36 | -12.20 | -13.09 | -11.82 | -15.27 | -14.44 | -16.30 | -15.84 | -23.44 | -22.33 | -19.87 | |||||
| Free Cash Flow Per Share TTM | -6.30 | -10.09 | -9.79 | -9.59 | -5.07 | -14.77 | -13.46 | -14.66 | -14.59 | -21.01 | -20.73 | -19.06 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Growth Metrics | |||||||||||||||||
| Net Income Growth (1Y) | 31.03% | 50.03% | 47.32% | 29.93% | 19.69% | 7.75% | 8.46% | 25.55% | 26.58% | 25.87% | 12.62% | -9.26% | |||||
| EPS Growth (1Y) | -56.50% | -19.04% | -15.52% | -19.72% | -25.38% | -34.88% | -35.34% | -17.94% | -36.12% | -31.92% | -38.67% | -50.42% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.88 | -0.43 | -0.90 | -1.60 | -1.89 | -2.14 | -2.85 | -4.14 | -2.99 | -2.37 | -2.45 | -1.75 | |||||
| P/B TTM | 2.28 | 0.93 | 4.08 | 4.43 | 3.42 | 2.36 | 5.04 | 11.16 | 6.67 | 3.59 | 10.66 | 3.28 | |||||
| Market Cap | 24.53M | 12.06M | 23.97M | 38.86M | 40.45M | 40.32M | 51.74M | 77.18M | 53.48M | 41.36M | 40.98M | 26.01M | |||||
| Enterprise Value | 20.61M | 5.12M | 21.04M | 33.55M | 32.93M | 43.16M | 44.76M | 73.29M | 48.43M | 32.12M | 38.93M | 19.68M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -34.35M | -23.05M | -21.48M | -17.74M | -9.18M | -18.21M | -16.94M | -16.77M | -16.46M | -15.65M | -15.56M | -14.24M | |||||
| Net Debt | -3.92M | -6.94M | -2.94M | -5.32M | -7.52M | 2.84M | -6.99M | -3.89M | -5.05M | -9.23M | -2.05M | -6.33M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Modular Medical, Inc. (MODD) — SEC Financial Statements & Analysis
Modular Medical, Inc. (MODD) is a surgical & medical instruments & apparatus company, incorporated in NV. Modular Medical, Inc. trades on Nasdaq as: MODD. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Modular Medical, Inc. reported a Debt-to-Equity ratio of 0.14x, a Price-to-Book (P/B) ratio of 2.28x (TTM), at a market cap of $24.53M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 0.14x
- P/B TTM
- 2.28x
- Market Cap
- $24.53M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Modular Medical, Inc. in?
Modular Medical, Inc. (MODD) operates in the Surgical & Medical Instruments & Apparatus industry.
What is MODD's market cap?
Modular Medical, Inc. (MODD) has a market capitalization of $24.53M as of 2026-06-30.
What exchange does MODD trade on?
Modular Medical, Inc. (MODD) trades on the Nasdaq.
Where is Modular Medical, Inc. incorporated?
Modular Medical, Inc. is incorporated in NV.